Difference in clinical implications of amniotic fluid C-peptide between second trimester and third trimester of pregnancy.
D000653:Amniotic Fluid / Q000032:analysis*; D002096:C-Peptide / Q000032:analysis*; D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis*; D006801:Humans; D007231:Infant, Newborn; D010455:Peptides / Q000032:analysis*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third
D002096:C-Peptide; D010455:Peptides